Guam vs Maldives: The number of people with susceptibility test result for rifampicin
Guam
35
in 2021
Maldives
46
in 2021
Guam rank
126th
Maldives rank
123rd
The number of people with susceptibility test result for rifampicin over time
- Guam
- Maldives
How they compare
Maldives currently reports 46 against 35 in Guam, a difference of 11.
That makes Maldives's figure about 1.3 times Guam's.
Across all 5 years both countries report, Maldives has been ahead every year.
Guam ranks 126th and Maldives ranks 123rd of 155 countries.
Maldives has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Guam | Maldives | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 50.33 | 76 | 25.67 | Maldives |
| 2020s | 36.5 | 44.5 | 8 | Maldives |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Guam or Maldives?
- Maldives, at 46 against 35 in Guam as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Guam and Maldives?
- 11, with Maldives ahead.
- How many years of comparable data are there for Guam and Maldives?
- 5 years are reported by both, from 2017 to 2021.
- How do Guam and Maldives rank globally for the number of people with susceptibility test result for rifampicin?
- Guam ranks 126th and Maldives ranks 123rd of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.